Delivery Order SPE2DB24D2011-SPE2DB24FBRCM

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.32 Firm Fixed Price delivery order is for the supply of 4,559,465,173 units of 4 mg Glimepiride tablets. The award was made on December 28, 2022, with a period of performance through December 29, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, held by...
This federal contract award, valued at $2,235.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order, with a firm-fixed price pricing type, and the ultimate completion date is April 23, 2025. The contract is for the delivery of 4,567,997,993 units of the medication Glimepiride 4 mg tablet in 100-count packages. This award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,153.02 Firm Fixed Price delivery order contract covers the supply of 4567721896 - GLIMEPIRIDE 4 MG TABLET 100S, with a performance period through March 28, 2025. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, Corporate Office Division, a firm-fixed-price delivery order contract valued at $1,286.16 for the supply of 4,565,784,148 glimepiride 4 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products to the U.S. federal government. This delivery order is part of the company's broader...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $1,170.74, is for the supply of Glimepiride 2 mg tablets in 100-count bottles. The award has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $2,284.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,058,247 units of the medication Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm fixed price and an ultimate completion date of April 29, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,150.86 firm fixed-price delivery order is for the supply of 4565266288 - Glimepiride 4 mg Tablets, 100s. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,451.03 firm fixed price delivery order is for the supply of 4564000979 - GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024 and does not have any set-aside designation....
This federal contract award is a delivery order worth $3,252.01 issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,564,340 units of glimepiride 1 mg tablets. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,322.54 Firm Fixed Price Delivery Order is for the provision of 4,564,326,421 tablets of the pharmaceutical drug Glimepiride 4 mg. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBRCM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $5,969.82 Firm Fixed Price Delivery Order is for the supply of 4 milligram Glimepiride tablets (100 count) to support military treatment programs and facilities. The contract has a completion date of September 12, 2024 and is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2025. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts to provide a wide range of essential medical commodities including specialty medications, generic drugs, and medical supplies to various defense and civilian agencies. This specific award does not use a set-aside designation.

Generated 12/11/24, 9:38 AM